# Bluerock Homes Trust, Inc.: financial statements, quarterly

BHM · NYSE · CIK 1903382 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bhm.md) · [Financials](/companies/bhm/financials.md) · [Filings](/companies/bhm/filings.md) · [Insiders](/companies/bhm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bhm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-09-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | period not labelled (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [10.2](/filings/0001410578-24-001981.md) | [10.5 d](/filings/0001410578-25-000400.md) | [11.2](/filings/0001410578-25-001149.md) | [12.5](/filings/0001410578-25-001745.md) | [12.7](/filings/0001104659-25-107723.md) | [13.8 d](/filings/0001104659-26-021568.md) | [16.4](/filings/0001104659-26-057077.md) | [16.8](/filings/0001104659-26-095875.md) | [16.6](/filings/0001104659-25-107723.md) | [18.9 d](/filings/0001104659-26-021568.md) | [19.7](/filings/0001104659-26-057077.md) | [19.3](/filings/0001104659-26-095875.md) |
| Operating income | $m | [(3.8)](/filings/0001410578-23-002300.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [3.5](/filings/0001410578-24-001981.md) | [4.4 d](/filings/0001410578-25-000400.md) | [3.5](/filings/0001410578-25-001149.md) | [4.1](/filings/0001410578-25-001745.md) | [5.2](/filings/0001104659-25-107723.md) | [5.3 d](/filings/0001104659-26-021568.md) | [6.2](/filings/0001410578-25-001149.md) | [5.6](/filings/0001410578-25-001745.md) | [5.7](/filings/0001104659-25-107723.md) | [6.5 d](/filings/0001104659-26-021568.md) | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.3](/filings/0001104659-26-057077.md) | [0.6](/filings/0001104659-26-095875.md) | [0.4](/filings/0001104659-25-107723.md) | [0.3 d](/filings/0001104659-26-021568.md) | [0.1](/filings/0001104659-26-057077.md) | [0.0 d](/filings/0001104659-26-095875.md) |
| Net income | $m | [(3.6)](/filings/0001410578-24-001981.md) | [(5.7) d](/filings/0001410578-25-000400.md) | [(3.2)](/filings/0001410578-25-001149.md) | [(5.2)](/filings/0001410578-25-001745.md) | [3.5](/filings/0001104659-25-107723.md) | [(7.3) d](/filings/0001104659-26-021568.md) | [(7.3)](/filings/0001104659-26-057077.md) | [(5.8)](/filings/0001104659-26-095875.md) | [(10.0)](/filings/0001104659-25-107723.md) | [(9.5) d](/filings/0001104659-26-021568.md) | [(10.3)](/filings/0001104659-26-057077.md) | [(9.0)](/filings/0001104659-26-095875.md) |
| Diluted EPS | $ per share | [(0.28)](/filings/0001410578-24-001981.md) | not reported | [(0.27)](/filings/0001410578-25-001149.md) | [(0.42)](/filings/0001410578-25-001745.md) | [0.24](/filings/0001104659-25-107723.md) | not reported | [(0.67)](/filings/0001104659-26-057077.md) | [(0.66)](/filings/0001104659-26-095875.md) | [(0.94)](/filings/0001104659-25-107723.md) | not reported | [(0.90)](/filings/0001104659-26-057077.md) | [(0.90)](/filings/0001104659-26-095875.md) |
| Basic EPS | $ per share | [(0.28)](/filings/0001410578-24-001981.md) | not reported | [(0.27)](/filings/0001410578-25-001149.md) | [(0.42)](/filings/0001410578-25-001745.md) | [0.24](/filings/0001104659-25-107723.md) | not reported | [(0.67)](/filings/0001104659-26-057077.md) | [(0.66)](/filings/0001104659-26-095875.md) | [(0.94)](/filings/0001104659-25-107723.md) | not reported | [(0.90)](/filings/0001104659-26-057077.md) | [(0.90)](/filings/0001104659-26-095875.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-09-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | period not labelled (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [89.4](/filings/0001410578-24-001981.md) | [80.2](/filings/0001410578-25-000400.md) | [92.3](/filings/0001410578-25-001149.md) | [116](/filings/0001410578-25-001745.md) | [155](/filings/0001104659-25-107723.md) | [115](/filings/0001104659-26-021568.md) | [135](/filings/0001104659-26-057077.md) | [128](/filings/0001104659-26-095875.md) | [2.1](/filings/0001104659-26-021568.md) | [170](/filings/0001104659-26-095875.md) | [170](/filings/0001104659-26-057077.md) | [172](/filings/0001104659-26-095875.md) |
| Total assets | $m | [671](/filings/0001410578-23-002300.md) | [672](/filings/0001410578-25-000400.md) | [727](/filings/0001410578-24-000698.md) | [756](/filings/0001410578-24-001224.md) | [801](/filings/0001410578-24-001981.md) | [967](/filings/0001104659-26-021568.md) | [186](/filings/0001410578-25-001745.md) | [220](/filings/0001104659-25-107723.md) | [222](/filings/0001104659-26-021568.md) | [1,154](/filings/0001104659-26-095875.md) | [1,143](/filings/0001104659-26-057077.md) | [1,147](/filings/0001104659-26-095875.md) |
| Total liabilities | $m | [182](/filings/0001410578-23-002300.md) | [193](/filings/0001410578-25-000400.md) | [238](/filings/0001410578-24-000698.md) | [240](/filings/0001410578-24-001224.md) | [245](/filings/0001410578-24-001981.md) | [398](/filings/0001104659-26-021568.md) | [2.7](/filings/0001410578-25-001745.md) | [2.6](/filings/0001104659-25-107723.md) | [2.8](/filings/0001104659-26-021568.md) | [463](/filings/0001104659-26-095875.md) | [448](/filings/0001104659-26-057077.md) | [455](/filings/0001104659-26-095875.md) |
| Long-term debt | $m | [97.1](/filings/0001410578-23-002300.md) | [96.7](/filings/0001410578-25-000400.md) | [120](/filings/0001410578-24-000698.md) | [120](/filings/0001410578-24-001224.md) | [123](/filings/0001410578-24-001981.md) | [253](/filings/0001104659-26-021568.md) | [251](/filings/0001410578-25-001149.md) | [339](/filings/0001410578-25-001745.md) | [394](/filings/0001104659-25-107723.md) | [428](/filings/0001104659-26-095875.md) | [417](/filings/0001104659-26-057077.md) | [422](/filings/0001104659-26-095875.md) |
| Shareholders' equity | $m | [155](/filings/0001410578-23-002300.md) | [147](/filings/0001410578-25-000400.md) | [144](/filings/0001410578-24-000698.md) | [143](/filings/0001410578-24-001224.md) | [143](/filings/0001410578-24-001981.md) | [139](/filings/0001104659-26-021568.md) | [137](/filings/0001410578-25-001149.md) | [135](/filings/0001410578-25-001745.md) | [132](/filings/0001104659-25-107723.md) | [129](/filings/0001104659-26-095875.md) | [125](/filings/0001104659-26-057077.md) | [121](/filings/0001104659-26-095875.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q1 FY2025 (2025-04-15) | period not labelled (2025-06-30) | Q2 FY2025 (2025-07-15) | period not labelled (2025-09-30) | Q3 FY2025 (2025-10-15) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | period not labelled (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.3 d](/filings/0001410578-25-001745.md) | [1.7 d](/filings/0001104659-25-107723.md) | [5.0 d](/filings/0001104659-26-021568.md) | [1.0](/filings/0001104659-26-057077.md) | not reported | [14.1 d](/filings/0001104659-26-095875.md) | not reported | [13.2 d](/filings/0001104659-25-107723.md) | not reported | [(0.5) d](/filings/0001104659-26-021568.md) | [(8.5)](/filings/0001104659-26-057077.md) | [2.8 d](/filings/0001104659-26-095875.md) |
| Capital expenditure | $m | [1.9 d](/filings/0001410578-25-001745.md) | [2.3 d](/filings/0001104659-25-107723.md) | [3.4 d](/filings/0001104659-26-021568.md) | [3.8](/filings/0001104659-26-057077.md) | not reported | [5.1 d](/filings/0001104659-26-095875.md) | not reported | [4.7 d](/filings/0001104659-25-107723.md) | not reported | [3.7 d](/filings/0001104659-26-021568.md) | [3.8](/filings/0001104659-26-057077.md) | [5.3 d](/filings/0001104659-26-095875.md) |
| Dividends paid | $m | [0.0 d](/filings/0001410578-25-001745.md) | [0.0 d](/filings/0001104659-25-107723.md) | [0.0 d](/filings/0001104659-26-021568.md) | not reported | [3.1](/filings/0001410578-25-001149.md) | not reported | [0.2 d](/filings/0001410578-25-001745.md) | [0.5 d](/filings/0001104659-25-107723.md) | [0.1 d](/filings/0001104659-25-107723.md) | [0.5 d](/filings/0001104659-26-021568.md) | [0.5](/filings/0001104659-26-057077.md) | [4.4](/filings/0001104659-26-095875.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-09-30) | Q1 FY2026 (2026-03-31) | period not labelled (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,844](/filings/0001410578-23-002300.md) | [3,844](/filings/0001410578-24-000698.md) | [3,844](/filings/0001410578-24-001224.md) | [3,846](/filings/0001410578-24-001981.md) | [3,848](/filings/0001410578-25-001149.md) | [3,852](/filings/0001410578-25-001745.md) | [3,871](/filings/0001104659-25-107723.md) | [3,865](/filings/0001104659-26-057077.md) | [3,896](/filings/0001104659-26-095875.md) | [3,898](/filings/0001104659-25-107723.md) | [3,898](/filings/0001104659-26-057077.md) | [3,941](/filings/0001104659-26-095875.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.